1. Academic Validation
  2. Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines

Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines

  • Bioorg Med Chem Lett. 1998 Oct 6;8(19):2731-6. doi: 10.1016/s0960-894x(98)00482-x.
L G Hamann 1 D T Winn C L Pooley C M Tegley S J West L J Farmer L Zhi J P Edwards K B Marschke D E Mais M E Goldman T K Jones
Affiliations

Affiliation

  • 1 Department of Medicinal Chemistry, Ligand Pharmaceuticals, San Diego, CA 92121, USA.
Abstract

A series of nonsteroidal human Progesterone Receptor (hPR) antagonists based on conformationally-restricted analogues of a 6-aryl-1,2-dihydro-2,2,4-trimethylquinoline pharmacophore were synthesized and evaluated for their ability to bind to the human Progesterone Receptor and inhibit progesterone-stimulated reporter gene expression in mammalian cells.

Figures